Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 ,inter alia, to consider and approve the audited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech has postponed its Board meeting from 9th June 2025 to 12th June 2025 to consider and approve its audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2025. The company had already missed the SEBI-mandated deadline of 30th May 2025 under Regulation 33 of the LODR. According to the filing, the delay is due to the consolidation of results from its subsidiaries and the completion of internal and external audit processes taking longer than expected. The Board meeting that was held on 9th June was adjourned after running from 4:00 PM to 8:00 PM. The trading window for designated persons remains closed until 48 hours after the results are declared.
This is a regulatory compliance delay and does not directly affect shareholder value, but repeated postponements of financial results may dent investor confidence and signal operational or accounting complexities within the company's subsidiaries. Retail investors should await the results on 12th June for clarity on actual financials.